465 This modulatory effect holds promise for ameliorating sympathetic activity in individuals with hypertension, as these agents lower blood pressure levels
31,35-37 Prospective trials are needed to further explore this potential adverse event and worsened DR, which is the central premise of the ophthalmic FOCUS trial that is expected to release results in 2026
A prespecified subgroup analysis for the primary outcome was conducted for patients who underwent upper endoscopy with colonoscopy (clear liquid diet the day prior to the procedure) or upper endoscopy only (regular diet the day prior to the procedure)
According to the Cleveland Clinic, the higher the dose of the GLP-1 agonist, the more extreme the effects
Like other GLP-1 drugs, Foundayo can cause side effects such as nausea, constipation, diarrhea, vomiting, abdominal pain, and headache, according to the FDA